Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down After Analyst Downgrade

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC - Get Free Report) shares gapped down prior to trading on Wednesday after Wedbush lowered their price target on the stock from $20.00 to $17.00. The stock had previously closed at $12.67, but opened at $10.25. Wedbush currently has an outperform rating on the stock. Oric Pharmaceuticals shares last traded at